1.山东中医药大学中医学院,山东省济南市长清区大学路4655号,250014
2.山东中医药大学第一临床医学院
3.山东中医药大学附属医院
chenxianhai18@163.com
收稿:2022-11-23,
修回:2022-12-25,
纸质出版:2023-04-17
移动端阅览
成晓萌,胡渊龙,阮梽珅等.基于“清浊相干”理论探讨慢性阻塞性肺疾病频繁加重表型的防治[J].中医杂志,2023,64(08):784-789.
CHENG Xiaomeng,HU Yuanlong,RUAN Zhishen,et al.Prevention and Treatment of Frequent Exacerbation Phenotype of Chronic Obstructive Pulmonary Disease Based on the Theory of “Mutual Interference between the Clear and the Turbid”[J].Journal of Traditional Chinese Medicine,2023,64(08):784-789.
成晓萌,胡渊龙,阮梽珅等.基于“清浊相干”理论探讨慢性阻塞性肺疾病频繁加重表型的防治[J].中医杂志,2023,64(08):784-789. DOI: 10.13288/j.11-2166/r.2023.08.007.
CHENG Xiaomeng,HU Yuanlong,RUAN Zhishen,et al.Prevention and Treatment of Frequent Exacerbation Phenotype of Chronic Obstructive Pulmonary Disease Based on the Theory of “Mutual Interference between the Clear and the Turbid”[J].Journal of Traditional Chinese Medicine,2023,64(08):784-789. DOI: 10.13288/j.11-2166/r.2023.08.007.
慢性阻塞性肺疾病(COPD)患者每年出现≥2次的中度急性加重或≥1次的重度急性加重属于COPD“频繁加重表型”。认为“清浊相干”是COPD频繁加重表型的中医基本病机,宗气下陷是其初始病机阶段,营卫不和是其关键病机环节。宗气下陷,营卫气弱,致外邪频犯机体,卫气逆行,清浊不相顺接而津液气血输布受阻,进一步导致痰瘀互结、复伤正气。因此,对COPD频繁加重表型的中医基本防治原则为:在COPD频繁加重表型未形成时,以培土生金、升补宗气、益气固表,阻断“清浊相干”的病机进程,减缓COPD频繁加重表型的形成速度;在COPD频繁加重表型已形成时,则在补益虚损的基础上以清化内浊为治疗原则,旨在清除“清浊相干”带来的主要病理产物,降低COPD纵向及横向传变风险。COPD频繁加重表型的形成、传变以及方药干预的动态生物标志物和生物学机制是未来需要进一步探索的方向。
The frequent exacerbation phenotype of chronic obstructive pulmonary disease (COPD) is defined as occurrence of more than two moderate exacerbations or one severe exacerbation per year. It is believed that “mutual interference between the clear and the turbid” is the basic pathogenesis in traditional Chinese medicine (TCM), while sinking of pectoral
qi
(gathering
qi
or ancestral
qi
) is the initial stage, and disharmony between
ying
(营) and
wei
(卫)
qi
is the key stage of pathological mechanism. As the pectoral
qi
sinks, and
ying
and
wei qi
were weak, the external pathogens invade the body frequently, leading to
wei
qi
counterflow and disorder of the clear and the turbid connection; the transport and distribution of the fluids, essence,
qi
, and blood are then affected, which produces the binding of phlegm and stasis, and damage of healthy
qi
once again. Therefore, the basic prevention and treatment principle for frequent exacerbation phenotype of COPD is to block the progression of “mutual interference between the clear and the turbid” before the formation of frequent exacerbation phenotype of COPD, and to slow down the formation by banking up earth to generate metal, up-regulating and supplementing pectoral
qi
, and boosting
qi
to consolidate the exterior; after the frequent exacerbation phenotype of COPD is formed, the treatment principle should be clearing and removing internal turbidity together with supplementing and boosting the deficiency, which is aimed at eliminating the main pathological products of “mutual interference between the clear and the turbid”, and reducing the vertical and horizontal transmission risk of COPD. Further researches are warranted regarding the formation and transmission of the frequent exacerbation phenotype of COPD, the dynamic biomarkers and the underlying biological mechanismsin the future.
SADATSAFAVI M , MCCORMACK J , PETKAU J , et al . Should the number of acute exacerbations in the previous year be used to guide treatments in COPD? [J]. Eur Respir J , 2021 , 57 ( 2 ): 2002122 . doi: 10.1183/13993003. 02122-2020 http://dx.doi.org/10.1183/13993003.02122-2020 .
MATHIOUDAKIS AG , JANSSENS W , SIVAPALAN P , et al . Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits [J]. Thorax , 2020 , 75 ( 6 ): 520 - 527 .
CELLI B , LOCANTORE N , YATES JC , et al . Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort [J]. Eur Respir J , 2021 , 57 ( 3 ): 2001339 . doi: 10.1183/13993003.01339-2020 http://dx.doi.org/10.1183/13993003.01339-2020 .
吕梦菲 , 张其成 . 从“清浊”的逻辑问题谈中医象数思维的描述性特征 [J]. 中医杂志 , 2020 , 61 ( 8 ): 727 - 729 .
孙飞 , 杜武勋 , 张少强 . 《黄帝内经》“浊”及其相关概念的理论研究 [J]. 中医杂志 , 2015 , 56 ( 20 ): 1711 - 1715 .
张锡纯 . 医学衷中参西录 [M]. 太原 : 山西科学技术出版社 , 2009 : 281 - 283 .
孙宇洁 , 郭锦晨 , 纵艳平 , 等 . 基于《医旨绪余》小议孙一奎“宗营卫”三气学术思想特色 [J]. 陕西中医药大学学报 , 2020 , 43 ( 5 ): 54 - 56 .
李杨 , 李小娟 , 栾哲宇 . 从中医“因加而发”角度探析慢性阻塞性肺疾病的急性发作 [J]. 中国中医急症 , 2021 , 30 ( 6 ): 1020 - 1023 .
世界中医药学会联合会 . 国际中医临床实践指南:慢性阻塞性肺疾病 [J]. 世界中医药 , 2020 , 15 ( 7 ): 1084 - 1092 .
周文婷 , 邵晶晶 , 于峥 , 等 . 从卫气出处谈肺、脾、肾虚证的关系 [J]. 中国中医基础医学杂志 , 2019 , 25 ( 3 ): 284 - 285,299 .
唐银平 . 成都地区慢性阻塞性肺疾病频繁急性加重表型的临床特征及中医体质分析 [D]. 成都 : 成都中医药大学 , 2020 .
WU YK , SU WL , YANG MC , et al . Characterization associated with the frequent severe exacerbator phenotype in COPD patients [J]. Int J Chron Obst Pulmon Dis , 2021 , 16 : 2475 - 2485 . doi: 10.2147/COPD.S317177 http://dx.doi.org/10.2147/COPD.S317177 .
WEDZICHA JA , BRILL SE , ALLINSON JP , et al . Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease [J]. BMC Med , 2013 , 11 : 181 . doi: 10.1186/1741-7015-11-181 http://dx.doi.org/10.1186/1741-7015-11-181 .
MACINTYRE N , HUANG YC . Acute exacerbations and respiratory failure in chronic obstructive pulmonary disease [J]. Proc Am Thorac Soc , 2008 , 5 ( 4 ): 530 - 535 .
罗美 . 内经博议 [M]. 北京 : 中国中医药出版社 , 2019 : 90 .
丁元庆 . 卫气失常与慢性阻塞性肺疾病病机相关性探讨 [J]. 山东中医杂志 , 2018 , 37 ( 7 ): 533 - 537 .
DAY K , OSTRIDGE K , CONWAY J , et al . Interrelationships among small airways dysfunction, neutrophilic inflammation, and exacerbation frequency in COPD [J]. Chest , 2021 , 159 ( 4 ): 1391 - 1399 .
GEERDINK JX , SIMONS SO , PIKE R , et al . Differences in systemic adaptive immunity contribute to the “frequent exacerbator” COPD phenotype [J]. Respir Res , 2016 , 17 ( 1 ): 140 .
张维波 , 王泽 , 宋晓晶 . 《黄帝内经》卫气卫外功能解析 [J]. 中国针灸 , 2021 , 41 ( 3 ): 343 - 347 .
傅强 , 赵进喜 , 王慧如 , 等 . 浅论气陷理论及临床意义 [J]. 中医杂志 , 2017 , 58 ( 15 ): 1270 - 1273 .
范艺龄 , 苗青 , 廖星 , 等 . 补中益气汤治疗慢性阻塞性肺疾病稳定期有效性和安全性的系统评价与Meta分析 [J]. 中国中药杂志 , 2020 , 45 ( 22 ): 5344 - 5355 .
MA J , ZHENG J , ZHONG N , et al . Effects of YuPingFeng granules on acute exacerbations of COPD: a randomized, placebo-controlled study [J]. Int J Chron Obstruct Pulmon Dis , 2018 , 13 : 3107 - 3114 . doi: 10. 2147/COPD.S170555 http://dx.doi.org/10.2147/COPD.S170555 .
胡渊龙 , 成晓萌 , 刘施吟 , 等 . 整合转录组学与网络药理学探讨黄芪-白术药对治疗慢性阻塞性肺疾病的机制 [J]. 中国中西医结合杂志 , 2020 , 40 ( 10 ): 1196 - 1201 .
章匀 , 孙建 . 浅述慢性阻塞性肺疾病从风痰瘀虚论治 [J]. 光明中医 , 2009 , 24 ( 8 ): 1552 - 1553 .
崔英海 , 胡镜清 , 李丁蕾 , 等 . 基于“痰瘀互结”理论论治慢性阻塞性肺疾病 [J]. 世界中医药 , 2021 , 16 ( 21 ): 3111 - 3115,3121 .
沈枭 , 何凌林 , 范伏元 . 基于中西医结合的慢性阻塞性肺疾病病机认识新思路 [J]. 中医药临床杂志 , 2020 , 32 ( 11 ): 2005 - 2008 .
任培中 , 弓雪峰 , 崔红生 , 等 . 从“大气下陷”探讨慢性重度呼吸困难的治疗思路与对策 [J]. 上海中医药杂志 , 2021 , 55 ( 7 ): 38 - 41 .
苗青 , 樊茂蓉 , 王京菊 , 等 . 论宗气亏虚是慢性阻塞性肺疾病横向传变的关键因素 [J]. 时珍国医国药 , 2009 , 20 ( 10 ): 2572 - 2573 .
PATEL AR , KOWLESSAR BS , DONALDSON GC , et al . Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease [J]. Am J Respir Crit Care Med , 2013 , 188 ( 9 ): 1091 - 1099 .
GULATI S , WELLS JM . Bringing stability to the chronic obstructive pulmonary disease patient: clinical and pharmacological considerations for frequent exacerbators [J]. Drugs , 2017 , 77 ( 6 ): 651 - 670 .
姚磊 , 柏永辉 , 陆文杰 , 等 . 升陷汤在慢性左心衰患者中的临床疗效评价和药物安全性研究 [J]. 中药材 , 2020 , 43 ( 2 ): 478 - 481 .
原淳淳 , 王晶 , 舒冰 , 等 . 中医表型组学的概念与相关研究体系的构建 [J]. 中医杂志 , 2022 , 63 ( 5 ): 407 - 411 .
HU Y , CHENG X , QIU Z , et al . Identification of metabolism-associated molecular subtypes of chronic obstructive pulmonary disease [J]. Int J Chron Obstruct Pulmon Dis , 2021 , 16 : 2351 - 2362 . doi: 10.2147/COPD.S316304 http://dx.doi.org/10.2147/COPD.S316304 .
0
浏览量
1
下载量
1
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号